novell pharmaceutical laboratories
 Search
Home | Contact Us    
our product
 
  Cardiovascular & Hematopoietic System
Haemotastic
 
Haemostop

Indications

Control of haemorrhage associated with severe fibrinolysis in haemorrhagic disease, haemoptosis, after operations or tooth extraction


Pharmacology

Each HAEMOSTOP 500 mg caplet contains:
Tranexamic Acid ………. 500 mg

Each ml of HAEMOSTOP 250 mg injection contains:
Tranexamic Acid ……….. 50 mg

Each ml of HAEMOSTOP 250 mg injection contains:
Tranexamic Acid ……….100 mg


Package Quantities

Box of  10 strips @ 10 caplets

Box of 5 ampoules @ 5 ml

Box of 5 ampoules @ 5 ml

 


 
     
copyright